nation
institut
biolog
standard
control
nibsc
human
materi
advisori
committe
project
approv
project
ministri
health
oman
ministri
health
saudi
arabia
korea
nation
institut
health
south
korea
donat
convalesc
serum
plasma
sampl
pcrconfirm
patient
patient
donor
gave
inform
consent
use
serum
plasma
sampl
anonym
treat
merscov
convalescentphas
serum
plasma
solvent
deterg
use
valid
method
ensur
residu
infecti
viru
store
studi
sampl
dispatch
ice
pack
particip
blind
code
studi
sampl
provid
particip
tabl
includ
plasma
sampl
sampl
individu
patient
sampl
smaller
serum
donat
pool
sampl
sampl
base
antibodi
titer
determin
use
recombiviru
human
merscov
nucleoprotein
np
antibodi
igg
elisa
kit
alpha
diagnost
intern
http
categor
sampl
high
medium
lowposit
pool
figur
includ
serum
antibodi
human
coronaviru
sampl
test
specif
assay
tabl
coauthor
mam
cd
precharacter
donat
sampl
purifi
human
mer
polyclon
antibodi
transchromosom
tc
cattl
immun
either
recombin
spike
protein
whole
inactiv
viru
sampl
donat
eddi
j
sullivan
sab
biotherapeut
inc
sioux
fall
sd
usa
dilut
materi
univers
buffer
mmoll
trishcl
ph
human
serum
albumin
trehalos
concentr
mgml
particip
laboratori
list
end
articl
locat
australia
china
mainland
hong
kong
germani
south
korea
netherland
unit
state
unit
kingdom
laboratori
particip
organ
includ
nation
control
laboratori
diagnost
laboratori
research
laboratori
particip
test
sampl
panel
use
routin
assay
merscov
serolog
ask
particip
perform
independ
assay
differ
day
provid
excel
spreadsheet
microsoft
http
wwwmicrosoftcom
report
raw
data
assay
interpret
result
posit
neg
diagnosi
sampl
combin
titer
rel
potenc
rel
titer
estim
unweight
geometr
mean
gm
sampl
laboratori
use
laboratori
gm
calcul
overal
unweight
gm
sampl
express
variabl
laboratori
use
geometr
coeffici
variat
gcv
sd
transform
estim
mitig
effect
potenti
outlier
calcul
robust
estim
use
r
packag
refer
particip
laboratori
code
number
randomli
alloc
laboratori
return
data
use
differ
assay
method
assay
result
separ
method
refer
accord
laboratori
number
assay
code
exampl
ppnt
pseudoparticl
neutral
test
tissu
cultur
infecti
dose
total
dataset
return
tabl
data
cover
rang
differ
assay
format
neutral
assay
elisa
immunofluoresc
test
microarray
gener
good
agreement
assay
test
studi
assay
quantit
measur
limit
detect
titer
sampl
vari
greatli
overal
determin
posit
neg
agre
assay
except
laboratori
mn
microneutr
fail
detect
posit
sampl
sampl
test
detect
posit
panel
neg
control
sampl
deem
neg
quantit
assay
instanc
laboratori
report
result
cutoff
sampl
assay
sampl
correctli
diagnos
neg
overal
test
algorithm
laboratori
detect
sampl
cutoff
dilut
assay
laboratori
detect
sampl
cutoff
dilut
assay
laboratori
detect
sampl
cutoff
dilut
test
particip
detect
pool
hightit
merscov
antibodi
pool
sampl
assay
tabl
detect
pool
b
mediumtit
pool
sampl
quantit
assay
mn
assay
laboratori
quantit
assay
particip
detect
high
pool
higher
titer
medium
pool
qualit
assay
assay
gave
borderlin
posit
equivoc
result
medium
pool
assay
euroimmun
elisa
http
wwweuroimmuncom
laboratori
inhous
immunofluoresc
assay
laboratori
lowposit
pool
pool
c
sampl
detect
posit
singl
assay
studi
alpha
diagnost
intern
mer
np
elisa
perform
laboratori
qualit
assay
particip
score
posit
purifi
igg
sampl
transchromosom
bovin
sampl
sampl
howev
quantit
assay
n
elisa
laboratori
alpha
diagnost
intern
mer
np
elisa
laboratori
sampl
score
neg
expect
np
assay
fail
detect
sampl
antibodi
rais
recombin
mer
spike
protein
howev
surpris
assay
detect
sampl
antibodi
rais
whole
inactiv
viru
individu
convalescentphas
plasma
sampl
saw
variabl
result
compar
pool
materi
despit
sampl
sampl
correctli
identifi
posit
test
sampl
correctli
diagnos
posit
test
identifi
borderlin
posit
laboratori
euroimmun
elisa
assay
sampl
difficult
individu
patient
plasma
detect
posit
neg
mn
assay
laboratori
equivocalposit
inhous
immunofluoresc
assay
laboratori
euroimmun
elisa
borderlineneg
lab
equivoc
lab
weak
posit
lab
sampl
weakest
posit
individu
sampl
test
panel
saw
titer
quantit
assay
detect
posit
compil
result
quantit
assay
individu
posit
plasma
sampl
figur
simplifi
comparison
assay
report
result
differ
laboratori
rel
either
transchromosom
bovin
igg
sampl
rais
whole
inactiv
viru
sampl
highposit
pool
human
serum
pool
sampl
express
data
potenc
rel
either
chosen
potenti
refer
prepar
assign
arbitrari
valu
observ
improv
agreement
test
tabl
figur
saw
greatest
reduct
variat
laboratori
smaller
sem
figur
smaller
percentag
geometr
coeffici
variat
gcv
tabl
use
pool
human
serum
sampl
standard
transchromosom
bovin
igg
rais
whole
viru
sampl
show
substanti
improv
agreement
laboratori
howev
elisa
method
includ
studi
could
identifi
sampl
posit
detect
sporad
case
merscov
continu
develop
new
vaccin
combat
diseas
remain
import
serosurveil
understand
exposur
diseas
sever
ill
person
expos
viru
import
serolog
assay
diagnosi
mer
case
also
consid
guidelin
laboratori
test
merscov
updat
januari
specif
includ
sampl
collect
suspect
merscov
case
serolog
guidelin
list
situat
laboratori
conduct
serolog
test
merscov
defin
sporad
merscov
case
molecular
test
nucleic
acid
amplif
method
possibl
part
investig
ongo
outbreak
serolog
survey
retrospect
analysi
extent
outbreak
collabor
studi
evalu
perform
assay
detect
merscov
antibodi
use
panel
serolog
sampl
laboratori
correctli
identifi
neg
sampl
panel
includ
contain
antibodi
coronavirus
impli
good
specif
assay
laboratori
report
posit
result
correctli
except
sampl
test
neg
assay
howev
result
demonstr
import
test
algorithm
observ
instanc
sampl
incorrectli
determin
neg
borderlineequivoc
singl
test
singl
laboratori
tabl
howev
laboratori
use
test
algorithm
involv
method
analysi
sampl
sporad
spuriou
result
correctli
diagnos
posit
neg
use
singl
assay
type
would
found
higher
proport
incorrect
result
result
sampl
pool
serum
sampl
patient
confirm
merscov
highlight
lack
sensit
assay
studi
investig
would
need
determin
antibodi
titer
pool
limit
detect
assay
target
n
protein
import
understand
whether
specif
window
time
clinic
sampl
serolog
taken
whether
patient
mount
detect
antibodi
respons
spike
protein
infect
inform
may
lead
updat
guidelin
laboratori
test
merscov
raw
titer
report
laboratori
perform
quantit
assay
vari
greatli
sampl
laboratori
tabl
use
refer
materi
assay
tighten
valu
laboratori
sampl
enhanc
compar
figur
reduc
gcv
percentag
laboratori
tabl
perhap
unsurprisingli
magnitud
reduct
gcv
percentag
noteworthi
merscov
exampl
import
emerg
pathogen
potenti
caus
outbreak
diagnost
test
emerg
pathogen
often
develop
outbreak
without
proper
valid
calibr
studi
show
import
use
standard
reagent
allow
better
comparison
result
differ
laboratori
interpret
result
differ
studi
clinic
trial
continu
face
emerg
pathogen
pose
signific
risk
human
health
import
use
experi
gain
studi
improv
respons
next
threat
standard
assay
key
issu
differ
group
around
world
work
develop
produc
novel
assay
vaccin
product
need
standard
merscov
serolog
discuss
wide
support
vaccin
institut
joint
symposium
merscov
vaccin
develop
seoul
south
korea
june
sever
potenti
vaccin
develop
immun
respons
elicit
efficaci
correl
protect
must
assess
use
refer
intern
standard
enabl
worldwid
harmon
assay
compar
result
differ
preclin
clinic
studi
assess
specif
sensit
method
crucial
improv
understand
use
limit
serolog
assay
emerg
diseas
littl
knowledg
diseas
progress
antibodi
profil
key
inform
avail
infecti
diseas
studi
particip
contribut
data
l
cali
victorian
infecti
diseas
refer
laboratori
melbourn
australia
c
li
nation
institut
food
drug
control
beij
china
l
zhao
w
tan
nation
institut
viral
diseas
control
prevent
chines
center
diseas
control
prevent
beij
china
peiri
perera
school
public
health
univers
hong
kong
hong
kong
china
c
drosten
institut
virolog
berlin
berlin
germani
c
kang
js
wang
korea
center
diseas
control
prevent
center
laboratori
control
infecti
diseas
chungcheonhbukdo
south
korea
b
haagman
nma
okba
depart
virosci
erasmu
medic
center
rotterdam
netherland
r
gopal
highcontain
microbiolog
nation
infect
servic
public
health
england
colindal
london
uk
myhil
g
mattiuzzo
nation
institut
biolog
standard
control
south
mimm
uk
n
thornburg
center
diseas
control
prevent
atlanta
georgia
usa
